| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |